Allotera Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-07-237/23/26 | Amended | $123,313,778 | $13,820,439 | Equity Only | 06b | SEC linkSEC |
| 2025-09-089/8/25 | New | $109,493,339 | $109,493,339 | Equity Only | SEC linkSEC | |
| 2021-07-237/23/21 | New | $37,233,405 | $37,233,405 | Equity Only | 06b | SEC linkSEC |
| 2021-07-237/23/21 | New | $98,500,011 | Unknown | Equity Only | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Matthew Cooper | Executive |
| Jan K Davidson | Executive |
| Drew Dennison | Director |
| Bosun Hau | Director |
| Ayman Kabakibi | Executive |
| Daniel M Kemp | Director, Executive |
| Peter Kiener | Director |
| Kevin Li | Director |
| John P Mc Kearn | Director |
| Natalie Mount | Director |
| Bali Muralidhar | Director |
| Niall O'donnell | Director |
| Kumar Srinivasan | Director, Executive |
| Cherry Thomas | Executive |
| Keith Vendola | Executive |
Industry: Other Health Care (See others in industry)
Address:
4260 Forest Park Ave., Suite 100
St. Louis, MO, 63110
Phone: 314-501-1968
St. Louis, MO, 63110
Phone: 314-501-1968